Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 71, Issue 9, Pages 1155-1157Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00228-015-1892-1
Keywords
Adalimumab; Crohn's disease; Pharmacokinetics; Population compartmental modeling; Monoclonal antibody